Guardant Health, Inc. (GH)
GH price $166.89 +4.30 +2.64%
- Ticker
- GH
- Price
- $166.89
- Change
- +4.30 +2.64%
- Market cap
- $22.40B
- P/E
- -46.59
- Forward P/E
- 189.78
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 51
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and…